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In the natural environment, animal and plant viruses often share ecological niches with microorganisms, but
the interactions between these pathogens, although potentially having important implications, are poorly
investigated. The present report demonstrates, in a model system, profound mutual effects of mycoplasma and
cardioviruses in animal cell cultures. In contrast to mycoplasma-free cells, cultures contaminated with Myco-
plasma hyorhinis responded to infection with encephalomyocarditis virus (EMCV), a picornavirus, but not with
poliovirus (also a picornavirus), with a strong activation of a DNase(s), as evidenced by the TUNEL (terminal
deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling) immunofluorescence assay and electro-
phoretic analysis of host DNA. This degradation was reminiscent of that observed upon apoptosis but was
caspase independent, judging by the failure of the specific pan-caspase inhibitor Q-VD-OPh to prevent it. The
electrophoretic mobility of the enzyme responsible for DNA degradation and dependence of its activity on ionic
conditions strongly suggested that it was represented by a DNase(s) of mycoplasma origin. In cells not infected
with EMCV, the relevant DNase was dormant. The possibility is discussed that activation of the mycoplasma
DNase might be linked to a relatively early increase in permeability of plasma membrane of the infected cells
caused by EMCV. This type of unanticipated virus-mycoplasma “cooperation” may exemplify the complexity
of pathogen-host interactions under conditions when viruses and microorganisms are infecting the same host.
In the course of the present study, it was also demonstrated that pan-caspase inhibitor zVAD(OMe).fmk
strongly suppressed cardiovirus polyprotein processing, illustrating an additional pitfall in investigations of
viral effects on the apoptotic system of host cells.
Traditionally, virologists are predominantly studying prop-
erties of individual viruses and much rarely interactions be-
tween different viruses. Even less attention is paid to interac-
tions between viruses and microbes, although animal and plant
viruses quite often share, in the natural environment, their
ecological niches with microorganisms. Interactions of mi-
crobes with viruses other than phages are essentially a virgin
soil of either virology or microbiology. The scarcity of relevant
information may be illustrated by a recent review focused on
the interaction between enteric viruses and enteric bacteria
(23). There is ground to believe, however, that the impact of
microbial flora on viral growth and pathogenicity (and vice
versa) is much broader and deeper than is currently thought.
One of the reasons for such a belief is the well-known effect of
bacteria (and of their metabolic products) on diverse signaling
systems of animal cells, in particular those involved in innate
immunity (14, 41, 85, 89). A recent relevant example is dem-
onstration that a prokaryotic infection may protect drosophila
from a variety of RNA viruses (39). On the other hand, viral
infection may significantly alter the outcome of concomitant
bacterial infections. For example, it was reported that herpes-
virus latency in mice may confer significant resistance to Lis-
teria and Yersinia pathogens (8).
The aim of the present report is to demonstrate, in a model
system, profound mutual effects of mycoplasma and cardiovi-
ruses during their interaction with animal cells. Cardioviruses,
a genus in the picornavirus family, are represented by such
widely investigated viruses as encephalomyocarditis virus
(EMCV) and its strain mengovirus (MV), as well as Theiler’s
murine encephalomyelitis virus (TMEV). Cardioviruses are
pathogens naturally affecting many animal species, in particu-
lar, rodents, pigs, and some primates (49). Recently, TMEV-
related viruses have been implicated in human pathology (1,
12, 21, 29, 45, 46, 51, 96). Picornaviruses, which also include
such viruses as poliovirus, hepatitis A virus, foot-and-mouth
disease virus, and many others, possess a 7.2–8 kb-long single-
stranded RNA genome of positive polarity and share general
features of their reproduction mechanism (2). The genomic
RNA contains a large single reading frame (certain strains of
TMEV, but not EMCV, encode also a protein, L*, in an
alternative frame; see reference 47) translated into a polypro-
tein, which is processed into a dozen “mature” proteins by a
series of proteolytic events.
Interaction of picornaviruses with susceptible cells may have
different outcomes: it may result in cytopathic (necrotic) effect
(CPE) or apoptotic death, or it may lead to persistent infec-
tion. The character of these outcomes has obvious implications
for the pathogenesis of the viral disease. Necrotic death is a
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strong trigger of inflammatory reactions. Apoptosis, which
leads to degradation of host DNA and fragmentation of cells
into membrane-coated so-called apoptotic bodies and their
eventual “consumption” by macrophages and other scavenger
cells, could limit not only the spread of the viral progeny but
also prevent potential damages to the neighboring cells caused
by inflammation. Therefore, apoptosis is generally considered
to represent a defensive host reaction. The fate of the picorna-
virus-infected cell depends on the genetic properties of the
both partners of virus-host interaction, as well as on the status
of cell differentiation and environmental conditions (3, 13, 69,
70, 79, 80, 86). In particular, cardioviruses may evoke apoptotic
reaction in certain, especially partially restrictive, cells (42, 43,
75, 76, 92).
Mycoplasmas are the smallest prokaryotic obligate parasites
devoid of cell wall and of many synthetic capabilities and able
to trigger a variety of diseases, such as pneumonia, uretritis and
many others; they also frequently contaminate cultured cells.
Mycoplasmas could be attached to plasma membrane of eu-
karyotic cells but in some cases they are able to invade the cells
as well. They may exert a variety of effects on signaling systems
of animal cells affecting, in particular, their innate immunity
(67, 71).
We will demonstrate here that, in several mycoplasma-con-
taminated cell cultures, infection with EMCV (but not with
poliovirus) results in activation of the microorganism-derived
DNase(s), which accomplishes degradation of host cell DNA
resembling that occurring during apoptosis but which was
caspase independent. The same but mycoplasma-free cells re-
spond to EMCV infection with a canonical CPE (70). This type
of unanticipated virus-mycoplasma “cooperation” may illus-
trate the complexity of pathogen-host interactions under con-
ditions when both viruses and microorganisms are present.
MATERIALS AND METHODS
Cells and viruses. HeLa-B cells (80), HeLa-3E cells constitutively expressing
3 EGFP-NLS, i.e., three copies of the enhanced green fluorescent protein
fused to the simian virus 40 nuclear localization signal (9), and RD (human
rhabdomyoblastoma) cells were grown on petri dishes in Dulbecco modified
Eagle medium with 10% fetal bovine serum at 37°C under 5% CO2. HeLa-3E
cells expressing baculovirus p35 protein (HeLa-p35) were obtained by lentiviral
transduction as described previously (30) using MarxIV-p35-puro as a vector.
MarxIV-p35-puro was generated by cloning of BamHI/XbaI fragment from a
p35-encoding plasmid into MarxIV–puro vector (both constructs were kindly
donated by Y. Lazebnik). As control, cells, HeLa-MIV, similarly transfected with
the empty MarxIV-puro vector (31) were used. Both types of transfected cells
were grown in the presence of 1.5 g of puromycin/ml.
To eliminate mycoplasma from contaminated cells, they were grown in Eagle
medium with 10% fetal bovine serum in the presence of 10 g of ciprofloxacin
hydrochloride (ICN Biomedicals)/ml. To check the efficiency of decontamina-
tion, the cured cells were subjected to a passage without the drug, followed by the
application of the cellular suspension onto FTA MicroCard (Whatman), three
washes with FTA purification reagent, two washes with TE buffer (10 mM
Tris-HCl and 0.1 mM EDTA [pH 8]), and subsequent PCR assay with the
primers GPO-3 and MGSO described previously (82).
EMCV, its strain MV, and poliovirus type 1 Mahoney strain were used. To
eliminate mycoplasma from possibly contaminated viruses, viral stocks were
subjected to 3 passages in mycoplasma-free RD cells in the presence of 10 g of
ciprofloxacin hydrochloride/ml.
Mycoplasma identification. Cells were detached from the substrate, pelleted
at 1,500  g for 10 min at 4°C, suspended in 20 mM Tris-HCl (pH 7.4)–10 mM
EDTA–0.5% Triton X-100, and incubated for 20 min at 4°C. The supernatant
obtained after centrifugation in Eppendorf centrifuge at 2,000 rpm for 5 min at
4°C was subjected to the sodium dodecyl sulfate (SDS)-phenol extraction, nucleic
acids were ethanol precipitated, dissolved in water placed onto Whatman paper,
and air dried. The material from the paper was eluted with 75 l of water and the
16S rRNA-based mycoplasma group-specific PCR was performed with 1-l elu-
ates essentially according to the protocol previously described (82) but using a
different pair of primers: GPO-3 and 5-ACTCCTACGGGAGGCAGCAGTA-
3. The PCR products were sequenced.
Infection and single-cycle growth experiments. Cells were detached by EDTA
treatment and plated onto 35-mm petri dishes (Corning-Costar) at a density of
105 cells/cm2 and cultivated overnight under 5% CO2 at 37°C in Eagle medium
with 10% fetal bovine serum. The growth medium was discarded, and the virus
was added in a volume of 1 ml to provide an input multiplicity of infection (MOI)
of 100 PFU/cell. After a 30-min incubation at room temperature, the cells were
washed off with 2.5 ml of Eagle medium, and 1 ml of serum-free Eagle medium
was added. After incubation at 37°C for the indicated time intervals, the cells
were detached from the substrate by EDTA treatment, combined with the
supernatant medium, subjected to three cycles of freezing-thawing, and frozen at
80°C until virus titer determination by plaque assay on RD cells.
EMCV replicon and luciferase assay. An EMCV-based luciferase-expressing
replicon (pE-luc) (4) was kindly donated by Ann Palmenberg. In this replicon,
the region encoding proteins 1C-1D (VP3-VP4) was replaced by the firefly
luciferase gene. Translation of the replicon RNA transcript generated active
luciferase. HeLa cells were transfected with in vitro-synthesized runoff tran-
scripts of the replicon using DEAE dextran as described previously (81). At the
indicated times, the cells were lysed and firefly luciferase levels were determined
by using the luciferase assay system (Promega) according to the recommenda-
tions of the manufacturer by using a Modulus luminometer (Turner Biosystems).
Apoptosis induction. Protein synthesis inhibitor cycloheximide (CHI; 100 g/
ml) or transcription inhibitor actinomycin D (ActD; 3 g/ml) was used as a
nonviral inducer of apoptosis. Restrictive poliovirus infection was used as a viral
inducer (80). To this end, guanidine-HCl (100 g/ml) was added to the infected
cells at an early step, 1.5 h postinfection (p.i.), and the cells were fixed for
microscopic analysis several hours thereafter. The broad-spectrum caspase in-
hibitors zVAD(OMe).fmk, zVAD.fmk, and Q-VD-OPh (MP Biomedicals, Inc.)
were used to suppress apoptosis.
TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick
end labeling) assay. Infected and mock-infected cells were grown on coverslips
for the time intervals indicated, stained with Hoechst-33342, and fixed at room
temperature with Safe Fix for 30 min. The cells were treated with 96 and 70%
ethanol and stored at 20°C. The assay was performed by using the apoptosis
detection system, Fluorescein kit (Promega) according to the manufacturer’s
instructions. The filter cube I3 was used for the registration of TUNEL-positive
cells.
DNA electrophoresis. DNA fragmentation was assayed essentially as described
previously (80). Briefly, the cells were detached from the plastic by EDTA
treatment, suspended in a buffer containing 20 mM EDTA and 10 mM Tris-HCl
(pH 7.4), and lysed with 0.5% Triton X-100 for 20 min on an ice bath. The
suspension was subjected to centrifugation in an Eppendorf Minifuge (12,000
rpm, 15 min, 4°C), and the nuclei-free supernatant was treated with phenol-SDS.
The nucleic acids were precipitated with ethanol, dissolved in 10 l of H2O, and
treated with RNase A (10 g/ml, 37°C, 30 min). The samples were subjected to
electrophoresis on 1.5% agarose gels.
DNase assay. Cells treated as indicated were collected by the EDTA treatment
and suspended in lysis buffer (137 mM NaCl, 10% glycerol, 1% NP-40, 20 mM
Tris-HCl [pH 7.8]). Samples were equalized according to their protein concen-
tration, supplemented with 2 sample buffer (2% SDS, 0.1% bromophenol blue,
10% glycerol, 350 mM -mercaptoethanol, 50 mM Tris-HCl [pH 6.8]), heated
for 10 min at 60°C, and applied to SDS-free polyacrylamide gels containing calf
thymus DNA (50 g/ml). After electrophoresis, the gels were fixed with 25%
isopropanol in 10 mM Tris-HCl (pH 7.5), for 30 min at room temperature.
Isopropanol was removed by two washes with 10 mM Tris-HCl (pH 7.5) for 30
min each; the gels were soaked in the appropriate reaction buffer at 37°C for 12 h
and stained with ethidium bromide for visualization. If not otherwise indicated,
the reaction buffer contained 3 mM concentrations (each) of CaCl2, MgCl2 and
MnCl2 and 10 mM Tris-HCl (pH 7.5).
In vitro translation. Translation of viral RNAs was performed in micrococcal
nuclease-treated S10 Krebs-2 ascites carcinoma cell lysates as described previ-
ously (50, 78). Briefly, viral RNA, 10 to 20 g/ml, was incubated in reaction
mixtures containing 50% (vol/vol) S10 lysates and the following compounds (the
final concentrations are indicated): 75 mM potassium acetate, 1 mM MgCl2, 12
mM ATP, 8 mM GTP, 5 mM CTP, 5 mM UTP, 200 mM creatine phosphate, 1
g of creatine kinase/ml, 5 Ci of [35S]methionine (200 Ci/mmol), and 0.2 mM
concentrations of 19 unlabeled L-amino acids. When appropriate, the mixtures
were supplemented with caspase inhibitors at the indicated concentrations. The
reactions were carried out for 3 h at 32°C and terminated by addition of sample
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buffer (105 mM -mercaptoethanol, 3% SDS, 6% glycerol, 90 mM Tris-HCl [pH
6.8]). The probes were resolved in 6 to 15% gradient polyacrylamide gel elec-
trophoresis and analyzed by autoradiography.
Microscopy and image processing. Fluorescence microscopy was performed
with Leica DMLS fluorescence microscope equipped with green I3 (for visual-
ization of TUNEL signals) and blue A (for Hoechst-stained nuclei) filter cubes.
The pictures were obtained with Leica Digital Camera 100. To stain the nuclei,
the cells, prior fixation, were incubated for 30 min with 5 g of Hoechst 33342
dye/ml added to the culture medium. For staining of dead cells, 0.25% trypan
blue in phosphate-buffered saline was used. The color images obtained by mi-
croscopy were transformed into the grayscale mode by using Adobe Photoshop
7.0. When appropriate, the brightness and contrast of the whole row of grayscale
pictures in a given panel were equally optimized (to make visible details pre-
sented in the color images) by using “brightness/contrast” tool of Adobe Pho-
toshop 7.0.
The agarose gels were captured with the DigiDoc-It Imaging System (UVP,
LLC). The developed films obtained upon autoradiography were converted into
am electronic form by a Snapscan 1212 (Agfa).
RESULTS
The response of HeLa and RD cells to EMCV (but not
poliovirus) infection is dramatically altered by the presence of
mycoplasma. As we showed recently, infection of mycoplasma-
free HeLa cells with wild-type cardioviruses, EMCV or MV,
leads to necrotic cytopathic death (70). There is nearly no host
DNA degradation, as judged by very faint, if any, TUNEL
signal (which reveals DNA breaks) and only quite moderate
DNA fragmentation to high-molecular-mass species visible
FIG. 1. Effect of EMCV infection on TUNEL staining of mycoplasma-free (A) and mycoplasma-contaminated (B) HeLa cells. HeLa cells were
infected at an input MOI of 100 PFU/cell and were assayed for TUNEL, stained with Hoechst 33342, and inspected under a phase-contrast
microscope at 7 h p.i. Mock-infected cells, cells treated with CHI for 5 h, and cells infected with poliovirus at an MOI of 2,000 PFU/cell for 7 h
without () or with () 100 g of guanidine-HCl (gua)/ml added at 1.5 h p.i. were used as controls. Insets demonstrate examples of respective
individual cells at a higher magnification. Extranuclear DNA in the mycoplasma-contaminated culture is marked by an arrow. The virus-infected
cells exhibited nuclear signs of CPE seen in DNA (Hoechst-33342-stained) and phase-contrast panels. Although EMCV infection did not elicit any
marked signs of apoptosis in the mycoplasma-free cells, positive TUNEL signals, a hallmark of apoptosis, were clearly seen in the majority of
infected mycoplasma-contaminated cells. On the other hand, phase-contrast investigation of the virus-infected cells demonstrated no appreciable
blebbing, in contrast to the CHI-treated apoptotic cells (insets). The presence of mycoplasma exerted no appreciable effect on the apoptogenic
effect of CHI and on cellular response to productive or restrictive (apoptogenic) infection with poliovirus.
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upon electrophoretic analysis. Importantly, EMCV-infected
cells acquired an antiapoptotic state as revealed by their failure
to develop apoptosis in response to the treatment with chem-
ical (e.g., ActD) or viral (restrictive poliovirus infection in the
presence of guanidine; see reference 80) apoptosis inducers
(70).
A batch of uninfected mycoplasma-contaminated HeLa cells
did not exhibit any major signs of pathology: TUNEL-positive
cells constituted a minute proportion of the population and, in
fact, were absent from the majority of microscopic fields (Fig.
1B), and only minimal degradation of host DNA to high-
molecular-mass species could be detected by electrophoresis
(Fig. 2B). However, extranuclear punctated staining by perme-
able DNA dye Hoechst 33342 could be observed, upon over-
exposure, in the majority of cells (Fig. 1B, arrow), suggesting
the presence of a microbial contaminant. The contaminant was
identified as mycoplasma by using PCR with appropriate prim-
ers and was classified as Mycoplasma hyorhinis by sequencing a
PCR-amplified variable segment of the 16S rRNA.
The response of these mycoplasma-contaminated HeLa cells
to EMCV markedly differed from that of mycoplasma-free
cultures, as documented by a very strong TUNEL signal in the
overwhelming majority of cells (Fig. 1B) and very intense DNA
degradation to heterogeneous fragments, in particular, oligo-
nucleosome-sized ones (Fig. 2B), the both features being typ-
ical of apoptosis. The cells, however, did not display such
apoptosis-associated signs as plasma membrane blebbing (Fig.
1B, inset) or nuclear fragmentation, although deformation of
nuclei and moderate chromatin condensation could readily be
observed upon Hoechst-33342 staining (Fig. 1B).These nuclear
alterations, typical of CPE associated with EMCV reproduc-
tion, did not appear to differ significantly from those observed
in mycoplasma-free EMCV-infected cells (Fig. 1A). Remark-
ably, the presence of mycoplasma did not appreciably change
HeLa cell response to poliovirus infection: in line with previ-
ous results (3, 80), there was no (or nearly no) signs of apop-
tosis upon productive infection with this virus, as judged by the
TUNEL assay (Fig. 1B) or DNA electrophoresis (see Fig. 4B).
The mycoplasma-contaminated HeLa cells responded to
known viral and nonviral inducers of apoptosis, such as abor-
tive poliovirus infection (Fig. 1) and CHI (Fig. 1 and 2) qual-
itatively in the same way as did mycoplasma-free cells, i.e., by
development of TUNEL-positive staining and by DNA frag-
mentation detectable electrophoretically. The presence of my-
coplasma did not markedly alter rapid apoptotic response of
HeLa cells to another apoptosis inducer, ActD (not shown).
Extensive DNA degradation, as judged by the TUNEL and
DNA electrophoretic assays, could also be observed in myco-
plasma-contaminated RD cells (Fig. 3), which are known (69)
to be deficient in functions of the apoptotic system, as judged
by their inability to develop apoptosis in response to abortive
poliovirus infection, as well as to some nonviral apoptosis in-
ducers (Fig. 3).
Thus, the mycoplasma-contaminated cells, in distinction
with mycoplasma-free cells, responded to EMCV infection by
FIG. 2. Effect of EMCV infection on DNA from mycoplasma-free
(A) and mycoplasma-contaminated (B) HeLa cells. The cells were
infected with EMCV and treated with CHI as indicated in the legend
to Fig. 1, and DNA was prepared and investigated by electrophoresis
as described in Materials and Methods. The marker slot (M) contained
GeneRuler DNA Ladder Mix (Fermentas) showing the DNA length
(base pairs). EMCV infection caused extensive DNA degradation in
the mycoplasma-contaminated but not mycoplasma-free cells, whereas
mycoplasma contamination did not enhance DNA degradation in the
CHI-treated apoptotic cells.
FIG. 3. Effect of EMCV infection on the DNA degradation in mycoplasma-contaminated RD cells. (A) Microscopic examination; (B) DNA
electrophoresis. The conditions for EMCV and poliovirus infection and for CHI-treatment were the same as in the legend to Fig. 1. Electrophoretic
analysis was performed with DNA samples from EMCV-infected cells taken at 5 and 7 h p.i., from poliovirus-infected cells (with or without
guanidine [gua]) at 8 h p.i., and from mock-infected cells at 7 h. EMCV induced a strong TUNEL signals in the cells that failed to develop apoptosis
in response to nonviral (CHI) and viral (poliovirus infection in the presence of guanidine) apoptosis inducers. The marker lane was contrasted
separately from the rest of the gel to improve bands visibility.
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extensive DNA degradation the feature usually considered as a
hallmark of apoptosis.
EMCV-triggered DNA degradation in mycoplasma-infected
HeLa cells could not be prevented by specific caspase inhibi-
tors. The enterovirus-induced apoptosis-related DNA frag-
mentation is known to be readily preventable by caspase
inhibitors, such as zVAD(OMe).fmk (3, 17). When this com-
pound and another broad-spectrum caspase inhibitor Q-VD-
OPh (18), hereinafter referred to as Q-VD, were tested for
their capacity to prevent the appearance of TUNEL-positive
signals in the mycoplasma-contaminated HeLa cells, surpris-
ingly discordant results were obtained. Whereas the former did
prevent this apoptosislike feature, the latter failed to do so
(Fig. 4A). The failure of Q-VD to affect the EMCV-triggered
appearance of TUNEL-positive cells could not be explained by
its inability to prevent apoptosis in our system. Indeed, the
compound clearly exhibited its antiapoptotic activity in the
mycoplasma-contaminated HeLa cells either abortively in-
fected with poliovirus or treated with CHI (Fig. 4B). More-
over, EMCV infection triggered DNA degradation in a signif-
icant proportion of mycoplasma-contaminated HeLa-p35 cells
constitutively expressing baculovirus antiapoptotic p35 protein
(22), as evidenced by both the TUNEL assay (Fig. 5A and B)
and DNA electrophoresis (Fig. 5C), although these effects
were slightly milder than in the virus-infected control HeLa-
MIV cells. On the other hand, the HeLa-p35 cells were fully
resistant to the apoptogenic activity of CHI (Fig. 5).
The observation that the effect of zVAD(OMe).fmk sharply
deviated from that of another apoptosis inhibitor hinted that
the former might have some additional side effect(s) on
EMCV reproduction. Indeed, it turned out that this inhibitor
prevented the development of virus-induced CPE and fully
suppressed the generation of infectious EMCV progeny (Fig.
6A), inhibited replication of the EMCV-based replicon (Fig.
6B), and interfered with processing of the viral polyprotein in
a cell-free system. As shown in Fig. 6C, conversion of large
precursors into smaller “mature” proteins was inhibited in a
drug concentration-dependent mode. This result strongly sug-
gested that the primary target of the inhibitor was the viral
protease 3C (or 3CD) responsible for the polyprotein process-
ing. The inhibitory effect of zVAD(OMe).fmk on EMCV re-
production was similarly exhibited in mycoplasma-contami-
nated and mycoplasma-free HeLa cells and also in L929 cells
(not shown). The drug also inhibited reproduction of MV and
replication of a MV-based replicon (data not shown). In con-
trast, Q-VD exerted no significant inhibition of EMCV (or
MV) reproduction (see also reference 70) or polyprotein pro-
cessing (Fig. 6). The distinct effects of zVAD(OMe).fmk and
Q-VD could not be explained by the difference in the concen-
trations used, since the former nearly fully suppressed EMCV
reproduction at 20 M (not shown), whereas the latter did not
appreciably affect cardiovirus polyprotein processing at 100
M (Fig. 6C). Another antiapoptotic drug, DEVD.cmk did not
affect MV reproduction either (not shown). These results were
consistent with the notion that zVAD(OMe).fmk, in addition
to its established anti-caspase activity, also suppressed the ac-
tivity of the cardioviral 3C (or 3CD) proteases responsible for
the viral polyprotein processing. As judged by the results of
cell-free translation experiments, zVAD.fmk [i.e., unmethyl-
ated form of zVAD(OMe).fmk] also inhibited EMCV polypro-
tein processing (Fig. 6C) and, by implication, 3C/3CD protease
activity, even though the effect of this inhibitor on viral repro-
duction was markedly less efficient compared to its O-methyl-
ated counterpart (not shown), likely due to its poor entry into
the cytoplasm. Regardless of the mechanism of the inhibitory
effect of zVAD(OMe).fmk on viral reproduction, its ability to
prevent EMCV-triggered degradation of DNA of mycoplasma-
infected cells suggested that this degradation was coupled to
the reproduction of the virus. On the other hand, the failure of
Q-VD (which appeared to be essentially devoid of detectable
side effects in the systems studied) to prevent this degradation
FIG. 4. Effect of caspase inhibitors on DNA degradation in EMCV-infected mycoplasma-contaminated HeLa cells. (A) Disparate effects of
zVAD(OMe).fmk and Q-VD. The cells were infected at an input MOI of 100 PFU/cell and were assayed for TUNEL, stained with Hoechst
33342, and inspected under phase microscope at 8 h p.i. zVAD(OMe).fmk at 100 M or Q-VD at 20 M were added to the appropriate samples
at the onset of infection. It can be seen that the former inhibitor but not the latter prevented the development of TUNEL signal in EMCV-infected
cells. As shown in Fig. 6, different effects of the two inhibitors were not due to differences in their concentrations. (B) Effects of Q-VD on DNA
degradation triggered by EMCV infection (8 h p.i.) or by bona fide apoptosis inducers, CHI (5 h p.i.), and restrictive poliovirus infection (8 h p.i.
with guanidine added at 1.5 h p.i.) The drug failed to prevent EMCV-triggered degradation of DNA, whereas degradation triggered by the
apoptosis inducers was completely suppressed.
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suggested that the degradation was due to a caspase-indepen-
dent mechanism.
Q-VD also did not prevent the appearance of TUNEL-
positive signal in EMCV-infected mycoplasma-contaminated
RD cells (not shown).
DNA degradation in mycoplasma-contaminated virus-in-
fected cells was accomplished by a microbial enzyme(s). Since
the host DNA degradation in mycoplasma-contaminated car-
diovirus-infected cells did not appear to be due to the conven-
tional caspase-dependent apoptosis, the nature of the enzyme
involved was investigated. To this end, the following approach
was used (61). The cell lysates were subjected to electrophore-
sis in semidenaturing DNA-containing polyacrylamide gels.
The gels were washed and incubated at 37°C in a reaction
buffer for 14 h, followed by staining with ethidium bromide.
The negative bands thus obtained reflected the electrophoretic
mobility of the active nucleases. The results demonstrated that
EMCV infection was accompanied by a strong activation of
several DNase species at 6 to 8 h p.i. (Fig. 7A), with their
number increasing during the course of infection. DNase
bands with similar mobility but a markedly lower intensity were
present in the cultures prior to viral infection as well (Fig. 7A).
Essentially the same pattern of DNase(s) activation was ob-
served during EMCV infection of mycoplasma-contaminated
RD cells (Fig. 7B). On the other hand, no, or nearly no,
activation, compared to the mock sample, was observed during
apoptosis triggered by CHI or during productive or abortive
(i.e., apoptosis-inducing) infection with poliovirus at a time
corresponding to completion of the reproduction cycle of this
virus under the permissive conditions (Fig. 7A). The caspase
inhibitor Q-VD did not prevent the EMCV-triggered enhance-
ment of DNase bands (Fig. 7C). Incubation at 37°C of the
lysates from mycoplasma-contaminated RD cells, mock-in-
fected or EMCV-infected, lead to an increase in the intensity
of DNase bands (Fig. 7D), suggesting that the activation of a
preexisting enzyme(s) took place. This effect was observed in
both types of samples but was more striking in lysates from the
virus-infected cells.
Properties of the enzyme were further studied in extracts of
RD cells to minimize possible contributions of host apoptotic
proteins (as indicated above, these cells possess a deficient
apoptotic machinery). The enzyme(s) was not inhibited by 10
M 6-DTAF {4-(4,6-dichloro-[1,3,5]-triazin-2-ylamino)-2-(6-
hydroxy-3-oxo-3H-xanthen-9-yl)-benzoic acid, also known as
DR396} (Fig. 8A), an inhibitor of the DNase gamma (77). It
was activated at 200 mM KCl (Fig. 8B), exhibited a marked
dependence on the presence of both Ca2 and Mg2 ions (Fig.
8C) and was active under a broad range of pH values with two
apparent optimal zones, at pH 6.5 and pH 8.5 to 9.0 (Fig. 8D).
These properties were similar to those of mycoplasma
DNase(s) (61, 63) and strongly suggested that the enzyme
activated upon cardiovirus infection of mycoplasma-contami-
nated cells was of the mycoplasma origin.
Increased permeability of plasma membrane in EMCV-in-
fected cells as a possible factor involved in mycoplasma DNase
activation. The results presented above suggested that infec-
tion of mycoplasma-contaminated HeLa cells with EMCV but
not with poliovirus strongly activated microbial DNase(s). One
of the possible reasons for these discordant effects of the two
viruses could be a stronger and earlier increase in plasma
membrane permeability in the cardiovirus-infected cells, as
evidenced by trypan blue staining. As shown in Fig. 9A, a
significant proportion of mycoplasma-free HeLa cells became
dye-stained by 7 h p.i. On the other hand, cells undergoing
productive poliovirus infection and exhibiting clear cytoplas-
mic and nuclear signs of CPE remained, at the same time,
unstained (appreciable staining could be observed only several
hours after completion of viral reproduction; see also refer-
ence 69), as were unstained cells with CHI-triggered apoptosis
(Fig. 9A). EMCV-elicited permeabilization of the plasma
membrane took place also in mycoplasma-contaminated cul-
ture, and a proportion of cells became stained already by 5 h
p.i., this proportion being markedly increased during the next
2 h (Fig. 9B). The number of TUNEL-positive cells increased
in the course of infection in parallel with accumulation of
trypan blue-stained cells, and the stained cells were usually
found to be TUNEL positive (Fig. 9B). The relevant alteration
FIG. 5. Effect of baculovirus p35 protein on DNA degradation in
EMCV-infected or CHI-treated mycoplasma-contaminated HeLa
cells. (A) HeLa-MIV (i.e., transformed with the empty vector) and
HeLa-p35 cells were infected with EMCV for 8.5 h or treated with
CHI for 4.5 h and processed for the TUNEL assay. (B) Quantification
of TUNEL-positive HeLa-MIV () and HeLa-p35 () cells infected
with EMCV or treated with CHI. Average data from two independent
experiments. The yield of infectious virus by 8 h p.i. was 3  104 and
6  104 PFU/cell in HeLa-MIV and HeLa-p35 cells, respectively.
(C) DNA electrophoresis was performed with samples taken from
EMCV-infected cells at 8.5 h p.i. and from CHI-treated cells after 4.5 h
of incubation with the inhibitor. Expression of p35 completely sup-
pressed the appearance of TUNEL-positive cells and DNA degrada-
tion triggered by CHI but only partially diminished these effects in the
case of EMCV infection.
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of plasma membrane permeability might facilitate entry of the
microorganism (or its protein products) into the animal cells.
One might hypothesize that the DNase involved in DNA
degradation in cells with damaged plasma membrane could
have originated from the serum, since DNase I is known to be
secreted in the bloodstream (74). As shown by the in-gel assay,
the serum used in our experiments did not contain detectable
amounts of nucleases similar to those described above (data
not shown). The serum addition to the mycoplasma-contami-
nated cells or to EMCV-infected mycoplasma-free cells did not
result in DNase activation but rather, in the later case, some-
what inhibited it (not shown), perhaps due to increased cell
viability. It became evident in these experiments with EMCV-
infected mycoplasma-contaminated HeLa cells that the corre-
lation between the proportion of trypan blue-stained and
TUNEL-positive cells was not absolute. At early steps of in-
fection, some microscope fields might contain a significant
proportion of the latter but nearly none of the former (not
shown). One of the possible explanations for this observation
could be a higher sensitivity of the TUNEL assay compared to
the trypan blue staining.
DISCUSSION
The present study describes a nontrivial interaction or “co-
operation” between an RNA virus and mycoplasma. Cultures
of mycoplasma-contaminated cells responded to infection with
EMCV with an apoptosis-resembling reaction: the virus-in-
fected cells exhibited a strong TUNEL-positive signal, and
their DNAs were degraded to fragments superficially similar to
the electrophoretic “ladder” typical of apoptosis. This degra-
dation, however, could not be prevented by a pan-caspase
inhibitor and appeared to be caused by DNase(s) of myco-
plasma origin. The activation of this DNase and/or its entry
into the nuclei was possibly facilitated by an increase in the
permeability of the cellular membranes due to the viral infec-
tion.
Nature of DNase(s) responsible for DNA degradation in
EMCV-infected mycoplasma-contaminated cells. DNA degra-
dation is a hallmark of apoptosis. Several DNases have been
shown or proposed to be involved in executing the apoptotic
DNA degradation. They could be assigned to two functional
classes: cell-autonomous nucleases and waste-management
nucleases (60, 74). The former are parts of the apoptotic ma-
chinery, whereas the latter are involved in the degradation of
DNA of engulfed apoptotic cells by macrophages and other
scavenger cells. In the context of the present study, cell-auton-
omous nucleases appear to be more relevant. Among them, the
following enzymes are thought to be most important for
apoptotic DNA degradation, CAD (caspase-activated DNase,
also known as DFF40), mitochondrial endonuclease G (EndopG),
FIG. 6. Effect of caspase inhibitors on cardiovirus reproduction and processing of the viral polyprotein. (A) Effect of zVAD(O-Me).fmk and
Q-VD (inset) on the reproduction of EMCV. (B) Effect of zVAD(O-Me).fmk on replication of the EMCV-based replicon. The efficiency of
replication is expressed in the relative luciferase units (RLU). (C) Effect of the inhibitors on in vitro processing of the EMCV polyprotein. EMCV
RNA was translated in extracts from Krebs-2 cells as described in Materials and Methods in the absence or presence of different concentrations
(M) of zVAD(O-Me).fmk, Q-VD (left panel), or zVAD.fmk (right panel). The generation of infectious progeny, replication of the replicon, and
processing of the polyprotein were strongly suppressed by zVAD(O-Me).fmk but were unaffected by Q-VD. The primary target of the drugs, the
polyprotein processing, was not inhibited by Q-VD even at 100 M, the concentration at which zVAD(O-Me).fmk was usually used. The
polyprotein processing was also inhibited by zVAD.fmk.
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and DNase . The DNase(s) responsible for the effects de-
scribed here were clearly distinct from these three nucleases.
Although the nuclease activity described in the present study
was dependent on the presence of both Mg2 and Ca2, nei-
ther CAD (88) nor EndoG (72, 87) require Ca2. Further-
more, the latter enzyme is inhibited by KCl concentrations
above 60 mM (87). The involvement of DNase gamma was
unlikely because of the failure of its inhibitor 6-DTAF, also
known as DR396 (77), to suppress the enzyme in our system.
The properties of the enzyme studied here were also clearly
different from those of a major waste-managing nuclease, lyso-
somal DNase II, the main difference being an acidic pH opti-
mum of the latter. The involvement of Mg2/Ca2-dependent
DNase I, another waste-managing nuclease, which could be
secreted into the bloodstream, was unlikely because, as men-
tioned above, our assay failed to detect appreciable amounts of
DNases in the serum used and because the addition of serum
resulted in a decrease rather than an increase in nucleolytic
activity.
On the other hand, the electrophoretic mobility and ionic
requirements of the nuclease activated in EMCV-infected my-
coplasma-contaminated cells were similar to those known for
mycoplasma nucleases (61, 63). Taking into account enzymo-
logical similarity and the fact that such nuclease activity could
only be detected in mycoplasma-contaminated cells, we con-
clude that it was of mycoplasma origin.
Influence of mycoplasmas and other “third partners” on the
outcome of virus-cell interactions. A fundamental point im-
plicit in the results presented here concerns the potential sig-
nificance of alterations in virus-cell interactions by the active
participation of a third partner, a microorganism or another
virus. In our system, the presence of mycoplasma certainly
changed the development of cellular pathology of virus-in-
fected cells and perhaps accelerated the virus-induced death.
This issue may be considered in a broader perspective. In
natural settings, viral infection rarely takes place under sterile
conditions and occurs most often within readily accessible or-
gans, i.e., the gastrointestinal or respiratory tracts. The out-
come of virus-cell interaction may be significantly altered by a
third participant, a virus or a microorganism. However, how
these “third-party” effects influence the mechanisms and out-
comes of virus-host interactions is poorly understood. For ob-
vious reasons, most studies have been carried out with human
immunodeficiency virus (HIV). In particular, interactions be-
tween HIV and different herpesviruses, such as Kaposi sarcoma-
associated human herpesvirus 8 and some other herpesviruses,
have been a subject of numerous studies. Reproduction of the
both partners could be affected (see the recent references (52,
56, and 94). Latent herpesvirus infection may make HIV sus-
ceptible to acyclovir, which fails to exhibit anti-HIV effect in
cells singly infected with HIV (53). Other viruses, both DNA-
FIG. 7. DNase activation in EMCV-infected mycoplasma-contam-
inated HeLa cells. (A) DNase bands obtained upon electrophoresis of
cell extracts in DNA-containing gels. Extracts were prepared from
mycoplasma-contaminated HeLa cells infected with EMCV for 6 and
8 h; mock-infected cells, cells infected with poliovirus (with or without
guanidine-HCl [gua], as in the legend to Fig. 1), as well as cells treated
with 100 g of CHI/ml for 4 h, were used as controls. The extracts were
analyzed as described in Materials and Methods. The positions of
marker proteins with the corresponding molecular masses in kilodal-
tons are indicated. Marked enhancement of DNase bands in the course
of EMCV infection was clearly visible. (B) Extracts were prepared
from mycoplasma-contaminated EMCV-infected RD cells at 7 h p.i.
DNase activation was obvious. (C) Failure of Q-VD to prevent acti-
vation of DNase(s) in EMCV-infected mycoplasma-contaminated
HeLa cells. The extract was prepared at 8 h p.i. The inhibitor, 20 M,
was added at the onset of infection. (D) DNase activation upon incu-
bation of extracts from mycoplasma-contaminated RD cells. Lysates
prepared from mock-infected () and EMCV-infected, () cells at 5 h
p.i. as indicated in Materials and Methods were incubated at 37°C for
the time intervals indicated prior to electrophoresis in the DNA-
containing gel. An increase in the band intensity, seen in both types of
samples, but especially in those derived from virus-infected cells, in-
dicates activation of the preexisting enzyme(s).
FIG. 8. Properties of the DNase(s) activated by EMCV infection of
mycoplasma-contaminated RD cells. Extracts were prepared at 7 h p.i.
and analyzed as described in Materials and Methods. The following
modifications of the incubation buffer (containing, with the exception
of panel C, 3 mM concentrations of MgCl2, CaCl2, and MnCl2) were
used: the presence () or absence () of 10 M 6-DTAF (A), differ-
ent concentrations of KCl (B), different concentrations of Mg2 and
Ca2 (C), and (D) different pH levels.
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and RNA-containing viruses, may also interfere with HIV re-
production (33, 84, 90). Nonapparent persistent infection with
a virus (e.g., SV5) may modulate the innate immune system of
host cells, altering thereby reproduction of another virus in
these cells (93).
Prokaryotes, as well as products of their metabolism, are
well known to be able to exert a variety of effects on the both
innate and adaptive immunity (14, 24, 41, 85, 89). In the con-
text of the present study, modulation of virus-cell interactions
by mycoplasmas is of special interest (20). Again, a variety of
effects of this microorganism on infection with HIV have been
described (58). In particular, it is relevant to mention that the
CPE of HIV in certain cell cultures could be observed only if
these cultures had been contaminated with mycoplasma. Some
data also suggested that mycoplasma coinfection may mark-
edly affect pathogenesis of AIDS, and it was hypothesized that
mycoplasma could be an important factor in the HIV epidem-
ics (58).
A recent report demonstrated that mycoplasma infection
could activate the NF-	B pathway in cultured cells and protect
them from apoptosis induced by genotoxic stress (55). Thus, it
is conceivable that under certain conditions mycoplasma con-
tamination may suppress virus-induced apoptosis, an effect
that would superficially be the opposite to that described here.
This adds one more cautionary note in interpreting the results
of virus infection of cultured cells and prompts the necessity of
adequate control for mycoplasma contamination.
The results presented here also demonstrate the possibility
of modulation of mycoplasma activity by concomitant viral
infection. It is conceivable that similar modulatory effects
could take place in natural settings as well.
Variability of the mycoplasma effects on cells infected with
different picornaviruses. A noteworthy observation reported
here is that, in contrast to cardioviruses, poliovirus infection of
the contaminated cells did not trigger mycoplasma DNase ac-
tivation, at least until the full-fledged CPE. The reason for
such dissonant behavior of two picornaviruses is unknown, but
it is tempting to relate it to different time courses of plasma
membrane alterations caused by the representatives of the two
picornaviral genera. Indeed, as shown in Fig. 9, a significant
proportion of the EMCV-infected cells became accessible to
trypan blue dye at the time of exponential accumulation of the
viral progeny. In poliovirus infection, such staining could be
detected in a significant proportion of the cells only hours after
completion of the infectious cycle (69). It may be noted that
some activation of mycoplasma DNase could be observed in
lysates prepared at such postmortem steps from poliovirus-
infected mycoplasma-contaminated cells as well (data not
shown).
Although membrane alterations in picornavirus-infected
cells have been the subject of numerous studies (16), the exact
nature of the plasma membrane permeabilization and damage
is not fully understood. A variety of mechanisms operating
during distinct steps of viral reproduction have been impli-
cated, but the relevant differences between various picornavi-
rus representatives attracted relatively little attention. Now
that we know how diverse are the mechanisms used by various
picornaviruses to affect the translation of host mRNA (34, 35,
48, 59, 78, 95), impair nucleocytoplasmic transport (6, 9, 10, 25,
36, 37, 50, 64, 65), suppress innate immunity (7, 26, 32, 38, 62,
68, 83, 91), or affect the apoptotic machinery of the target cells
(5, 11, 15, 40, 44, 54, 69, 73, 75, 86), we should not be surprised
by the possible variability of the viral effects on plasma mem-
brane integrity. The relevant data are, however, rather scarce.
Ambiguities in the interpretation of the TUNEL assay and
of effects of caspase inhibitors. As shown elsewhere (70), pro-
ductive EMCV infection of HeLa cells results in the acquisi-
tion by these cells of an antiapoptotic state. However, if the
cells are contaminated with mycoplasma, one may be mislead
by the virus’ ability to elicit a strong TUNEL-positive signal
and extensive DNA degradation, these features which are typ-
ical of bona fide apoptosis being erroneously interpreted as
evidence for the apoptogenic ability of EMCV. False-positive
results of the TUNEL and of some other assays for DNA
degradation have been repeatedly described (19, 28, 66), but
one should be especially careful in interpreting the results of
FIG. 9. Membrane alterations in HeLa cells upon EMCV infection
as revealed by trypan blue staining. (A) The majority of mycolplasma-
free cells undergoing EMCV infection (7 h p.i.) were stained, whereas
poliovirus-infected (7 h p.i.) or CHI-treated (5 h) cells were not.
Cytopathic changes and apoptotic nuclear fragmentation in the virus-
infected and CHI-treated cells, respectively, were clearly seen in the
DNA (Hoechst 33342-stained) samples. (B) Correlation between the
appearance of trypan blue-stained and TUNEL-positive cells after
EMCV infection (5 and 7 h p.i.) of a mycoplasma-contaminated HeLa
cell culture. The duration of incubation with 100 g of CHI/ml was 5 h.
The TUNEL-positive virus-infected cells were stained with trypan
blue, whereas the CHI-treated apoptotic cells were not.
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such assays in experiments with virus-infected tissue culture
cells, known to be not so rarely contaminated with myco-
plasmas.
The side effects of widely used and relatively well-character-
ized caspase inhibitors are another source of potential misin-
terpretations of virus-cell interactions. The first evidence that
the pan-caspase inhibitor zVAD(OMe).fmk is also an inhibitor
of proteolytic activity of 2Apro of rhinovirus 2 and coxsackievi-
rus B4 was reported by Deszcz et al. (27). In the case of
coxsackievirus B3, both 2A and 3C proteases appeared to be
suppressed by the drug (57). As far as cardioviruses are con-
cerned, we reported preliminary data on the inhibition of
EMCV protease 3Cpro by zVAD(OMe).fmk in 2006 (50a), and
these observations are detailed here. Very recently, similar
observations have been made with another cardiovirus, TMEV
(76). Thus, some conclusions about the relationships between
apoptosis, on the one hand, and virus reproduction, on the
other, derived from the experiments in which such inhibitors of
apoptosis had been used should perhaps be reconsidered.
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